http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101360478-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0046 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24 |
| filingDate | 2012-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101360478-B1 |
| titleOfInvention | Novel tetranuclear arene-ruthenium compound and pharmaceutical composition for preventing or treating cancer containing the same as an active ingredient |
| abstract | The present invention relates to a novel quaternary arene-ruthenium compound or a pharmaceutically acceptable salt thereof, which inhibits proliferation of human SK-hep-1 (liver cancer) or HCT-15 (rectal cancer) cells at low micromolar concentrations. In addition, it shows excellent anticancer activity by inhibiting the activity of cancer cells through apoptosis that regulates the cell growth cycle, it can be usefully used for the prevention and treatment of cancer. |
| priorityDate | 2012-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.